Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
3.
Retina ; 38(10): 2064-2066, 2018 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28796148

RESUMO

PURPOSE: To investigate ocular bacterial count before and after antisepsis with aqueous chlorhexidine (AC) or povidone-iodine (PI) and to assess discomfort with each agent. METHODS: Bacterial swabs were taken from participants' eyes before and after antisepsis. These underwent microscopy, culture, and sensitivity testing. Aqueous chlorhexidine drops were administered to left eyes and PI to right eyes. Participants rated their pain (scale 0-10) for each eye but were blinded to the type of drop. RESULTS: There were 20 participants (17 women, 3 men), and the mean age was 43 years. Pain scores were significantly higher in right (PI) than in left (AC) eyes (mean 7 vs. mean 2, P < 0.001). No abnormalities were detected on specimen microscopy and gram staining. Seven preantisepsis swabs (three left and four right) grew bacteria in culture. Two postantisepsis swabs grew bacteria in primary culture plate (1 after AC and 1 after PI). For an additional one post-PI swab, bacteria were detected in enrichment broth only. CONCLUSION: The efficacy of AC and PI are similar, and patient discomfort is lower with AC. Aqueous chlorhexidine is a good alternative to PI for antisepsis before intravitreal injection.


Assuntos
Anti-Infecciosos Locais/administração & dosagem , Antissepsia/métodos , Clorexidina/administração & dosagem , Infecções Oculares Bacterianas/prevenção & controle , Dor Ocular/induzido quimicamente , Povidona-Iodo/administração & dosagem , Administração Oftálmica , Adolescente , Adulto , Idoso , Anti-Infecciosos Locais/efeitos adversos , Bactérias/isolamento & purificação , Clorexidina/efeitos adversos , Olho/microbiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Povidona-Iodo/efeitos adversos , Infecção da Ferida Cirúrgica/prevenção & controle , Adulto Jovem
5.
Int Ophthalmol ; 37(1): 303-312, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27160273

RESUMO

Demodex brevis and Demodex folliculorum are likely ubiquitous organisms associated with human eyelashes. However, they have also been implicated in the pathogenesis of external ocular diseases. This article reviews the current literature in regards to life cycle, morphology, pathogenesis and treatment of underlying Demodex spp. infestation and outlines the previously undescribed in vivo behaviour of the mites. Images were obtained from the epilation of lashes from 404 patients seen in clinical practice. Epilated lashes were placed on a microscope slide which had been coated with optically clear hypromellose/carbomer gel (Genteal gel, Novartis pharmaceuticals corporation, East Hanover, New Jersey). Adults were identified with either dark field or standard transmission microscopy at 40-100×. Eggs and other life-cycle stages were examined at 250× magnification, with transmission microscopy giving the best image resolution. The life cycle of the mite has been reviewed and simplified according to clinical observations. Clinical signs suggestive of underlying Demodex spp. infestation have been described, and their pathogenesis was explained based on the micrographic digital images obtained. The problem of symptomatic Demodex spp. disease likely reflects an imbalance in the external ocular ecology; however, the role of Demodex spp. as a commensal should not be overlooked. Treatment should not be aimed at total eradication of the mite but rather restoring the ocular ecology to a balanced state. By revisiting the life cycle of the mite, we can identify areas where possible intervention may be effective.


Assuntos
Infecções Oculares Parasitárias/parasitologia , Infestações por Ácaros/parasitologia , Ácaros , Animais , Blefarite/parasitologia , Infecções Oculares Parasitárias/diagnóstico , Pestanas/parasitologia , Humanos , Estágios do Ciclo de Vida , Infestações por Ácaros/diagnóstico , Ácaros/classificação , Ácaros/fisiologia
7.
J Cataract Refract Surg ; 42(6): 948-50, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-27373410
9.
Clin Exp Ophthalmol ; 44(7): 570-573, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26946462

RESUMO

BACKGROUND: To evaluate the visual outcomes of femtosecond laser-assisted cataract surgery (LCS) compared with phacoemulsification cataract surgery (PCS) in patients undergoing Toric IOL insertion. DESIGN: A non-randomized, single surgeon, prospective, comparative cohort case series PARTICIPANTS: Patients undergoing LCS and PCS between January 2012 and July 2014 at a single center. METHODS: The LCS group underwent femtosecond laser pretreatment for the anterior capsulotomy and lens fragmentation. Otherwise standard phacoemulsification surgery and foldable toric intraocular lens insertion proceeded. MAIN OUTCOME MEASURES: Best corrected visual acuity (BCVA), uncorrected visual acuity (UCVA), pre and post operative cylinder and mean absolute refractive error. RESULTS: A total of 418 eyes from 323 patients were included in the study; with 95 eyes in the PCS group and 323 in the LCS group. There were 243 (75.5%) LCS eyes with a pre-operative BCVA of 20/40 or better and 54 (56.8%) in the PCS group (p < 0.001). For post-operative BCVA, 315 (97.5 %) LCS and 81 (85.3%) PCS eyes had a BCVA of 20/40 or better (p = <0.001). However, there was no significant difference for change in BCVA between the groups (mean gain in EDTRS letter 11.0 for LCS and 10.3 for PCS p = 0.64) or in MAE (mean 0.56D PCS vs 0.65D LCS p = 0.18). CONCLUSION: In patients receiving toric intraocular lenses, there is similar improvement in terms of letters gained with LCS and PCS. Overall, there is no additional benefit for patients undergoing LCS in this cohort.


Assuntos
Extração de Catarata/métodos , Terapia a Laser/métodos , Implante de Lente Intraocular , Pseudofacia/fisiopatologia , Visão Binocular/fisiologia , Acuidade Visual/fisiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos
11.
Int Ophthalmol ; 36(5): 691-6, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26843091

RESUMO

Demodex species (spp.) have previously been implicated in the pathogenesis of blepharitis. This study aims to correlate improvement in symptoms of external ocular disease with treatment of underlying Demodex spp. This is a prospective, observational case series of patients with chronic external ocular disease. Demodicosis was confirmed by microscopic examination of epilated eyelashes. The main outcome measure was response to the treatment (5 % tee tree oil) in regard to change in subjective symptoms utilising a symptom-based patient questionnaire assessment. Overall patients had a good response to the treatment in terms of improvement or resolution of symptoms, with 91 % of patients reporting at least some improvement in symptoms. The treatment of underlying Demodex spp. appears to result in improvement of symptoms in patients with long standing external ocular disease and underlying Demodex spp. infestation.


Assuntos
Conjuntivite/tratamento farmacológico , Síndromes do Olho Seco/tratamento farmacológico , Infecções Oculares Parasitárias/tratamento farmacológico , Doenças Palpebrais/tratamento farmacológico , Infestações por Ácaros/tratamento farmacológico , Ácaros , Óleo de Melaleuca/uso terapêutico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Anti-Infecciosos Locais/administração & dosagem , Anti-Infecciosos Locais/uso terapêutico , Criança , Conjuntivite/parasitologia , Síndromes do Olho Seco/parasitologia , Infecções Oculares Parasitárias/parasitologia , Pestanas/parasitologia , Doenças Palpebrais/parasitologia , Feminino , Humanos , Masculino , Glândulas Tarsais/efeitos dos fármacos , Glândulas Tarsais/parasitologia , Pessoa de Meia-Idade , Infestações por Ácaros/parasitologia , Estudos Prospectivos , Inquéritos e Questionários , Óleo de Melaleuca/administração & dosagem
12.
Ophthalmology ; 123(1): 178-82, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26526634

RESUMO

PURPOSE: To evaluate visual outcomes after femtosecond laser-assisted cataract surgery (LCS) with phacoemulsification cataract surgery (PCS). DESIGN: Prospective, multicenter, comparative case series. PARTICIPANTS: Consecutive patients undergoing femtosecond LCS or PCS with intraocular lens insertion. METHODS: A total of 1876 eyes of 1238 patients (422 male and 772 female) who underwent cataract surgery between January 2012 and June 2014 were included in the study: 1017 eyes from center A and 859 eyes from center B. Cases underwent clinico-socioeconomic selection. Patients with absolute LCS contraindications were assigned to PCS; otherwise, all patients were offered LCS and elected on the basis of their decision to pay (the out-of-pocket cost for LCS). Demographic and postoperative data were collected to determine differences between groups. MAIN OUTCOME MEASURES: Six-month postoperative visual and refractive outcomes. Masked subjective refractions were performed 2 to 6 months postoperatively. RESULTS: There were 988 eyes in the LCS group and 888 eyes in the PCS group. Baseline best-corrected visual acuity (BCVA) was better in LCS compared with PCS (20/44.0 vs. 20/51.5; P < 0.0003). Preoperative surgical refractive aim differed significantly between groups (LCS -0.28 vs. PCS -0.23; P < 0.0001). More patients who received LCS had Toric lenses implanted compared with PCS (47.4% vs. 34.8%; P < 0.0001). Postoperative BCVA was better after LCS (20/24.5 vs. 20/26.4; P = 0.0003) with a greater proportion of LCS cases achieving BCVA >20/30 (LCS 89.7% vs. PCS 84.2%; P = 0.0006) and 20/40 (LCS 96.6% vs. PCS 93.9%; P = 0.0077). However, PCS cases had more letters gained compared with LCS cases (13.5 vs. 12.5 letters; P = 0.0088), reflecting baseline BCVA differences. Mean absolute error was higher in LCS compared with PCS (0.41 diopters [D] vs. 0.35 D; P < 0.0011). The percentage of eyes within 0.5 D of error from preoperative aim refraction was higher in the PCS group (LCS 72.2% vs. PCS 82.6%; P < 0.0001). CONCLUSIONS: Femtosecond LCS did not demonstrate clinically meaningful improvements in visual outcomes over conventional PCS.


Assuntos
Terapia a Laser/métodos , Refração Ocular/fisiologia , Acuidade Visual/fisiologia , Idoso , Feminino , Seguimentos , Humanos , Masculino , Facoemulsificação/métodos , Período Pós-Operatório , Estudos Retrospectivos , Resultado do Tratamento
13.
J Cataract Refract Surg ; 41(11): 2373-8, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26703485

RESUMO

PURPOSE: To evaluate the incidence of postoperative clinical cystoid macular edema (CME) associated with femtosecond laser-assisted cataract surgery (Catalys laser system) versus phacoemulsification cataract surgery. SETTING: Launceston Eye Institute, Launceston, Tasmania, Australia. DESIGN: Nonrandomized, single-surgeon, prospective, comparative cohort case series. METHODS: Patients who had femtosecond laser-assisted cataract surgery and phacoemulsification cataract surgery between March 2012 and July 2014 were included in the study. The femtosecond laser-assisted cataract surgery group had anterior capsulotomy, lens fragmentation, with or without corneal incisions via femtosecond laser pretreatment. Standard phacoemulsification surgery and foldable acrylic intraocular lens insertion proceeded in all cases. All patients received topical nonsteroidal drops commencing 2 days preoperatively and continuing for 4 weeks postoperatively. The incidence of postoperative clinical CME (confirmed by optical coherence tomography) and comparison between groups were measured. The main outcome measure was the clinical CME rates. RESULTS: Of the eyes, 833 had femtosecond laser-assisted cataract surgery amd 458 had standard phacoemulsification cataract surgery. Both groups had similar baseline parameters. There were 7 cases of postoperative CME (0.8%) in the femtosecond laser-assisted cataract surgery group compared to 1 case (0.2%) in the phacoemulsification cataract surgery group, highlighting a trend toward greater cystoid macular edema in the femtosecond laser-assisted cataract surgery group. This correlated with a change in laser treatment speed (due to a software upgrade), suggesting that retinal safety thresholds need further careful analysis. CONCLUSION: Increased CME might be a subthreshold retinal injury safety signal after femtosecond laser pretreatment and warrants further study. FINANCIAL DISCLOSURE: There are no financial or conflicts of interest for any author.


Assuntos
Extração de Catarata/métodos , Terapia a Laser , Edema Macular/epidemiologia , Facoemulsificação/métodos , Complicações Pós-Operatórias , Idoso , Idoso de 80 Anos ou mais , Feminino , Angiofluoresceinografia , Humanos , Incidência , Edema Macular/diagnóstico , Edema Macular/etiologia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Tomografia de Coerência Óptica
14.
BMJ Case Rep ; 20152015 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-26628310

RESUMO

Chronic myeloid leukaemia is a myeloproliferative neoplasm characterised by granulocytic hyperplasia in the bone marrow and the presence of a specific cytogenetic abnormality known as Philadelphia chromosome with fusion of breakpoint cluster region (BCR) and ableson (ABL) genes. Retinopathy is a rare sight-threatening complication of chronic myeloid leukaemia, which occurs due to leucostasis in retinal blood vessels. We report a case of a patient who presented with visual impairment due to leucostasis, who was successfully managed by leucapheresis along with BCR-ABL tyrosine kinase inhibitor.


Assuntos
Leucaférese , Leucemia Mielogênica Crônica BCR-ABL Positiva/complicações , Transtornos da Visão/etiologia , Transtornos da Visão/terapia , Dasatinibe/uso terapêutico , Humanos , Masculino , Pessoa de Meia-Idade , Cromossomo Filadélfia , Inibidores de Proteínas Quinases/uso terapêutico
19.
GMS Ophthalmol Cases ; 5: Doc06, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-27625950

RESUMO

The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era. The Strampelli anterior chamber intraocular lens was created in 1953, and was primarily used to treat myopia and aphakia. Due to the positioning of the lens, it was associated with a number of complications, and was later modified to decrease the rate of significant complications, including endothelial cell loss. This paper describes a 62-year-old man, who has had a Strampelli intraocular lens (IOL) in situ for 52 years, with relatively few complications. The case provides a framework for reflection on the significant advances in the development of IOLs since the Strampelli era.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...